India · Delayed Price · Currency is INR Cohance Lifesciences Statistics
Total Valuation
BOM:543064 has a market cap or net worth of INR 120.74 billion. The enterprise value is 122.61 billion.
| Market Cap | 120.74B |
| Enterprise Value | 122.61B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 382.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 23.11% |
| Float | 137.07M |
Valuation Ratios
The trailing PE ratio is 199.11 and the forward PE ratio is 32.93.
| PE Ratio | 199.11 |
| Forward PE | 32.93 |
| PS Ratio | 11.42 |
| PB Ratio | 3.08 |
| P/TBV Ratio | 4.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 202.19 |
| EV / Sales | 11.59 |
| EV / EBITDA | 88.52 |
| EV / EBIT | 279.61 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 3.25 |
| Debt / FCF | n/a |
| Interest Coverage | 4.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.88% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 8.73M |
| Profits Per Employee | 500,330 |
| Employee Count | 1,212 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543064 has paid 98.00 million in taxes.
| Income Tax | 98.00M |
| Effective Tax Rate | 19.88% |
Stock Price Statistics
The stock price has decreased by -69.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -69.82% |
| 50-Day Moving Average | 456.88 |
| 200-Day Moving Average | 805.92 |
| Relative Strength Index (RSI) | 18.65 |
| Average Volume (20 Days) | 37,379 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543064 had revenue of INR 10.58 billion and earned 606.40 million in profits. Earnings per share was 2.35.
| Revenue | 10.58B |
| Gross Profit | 7.50B |
| Operating Income | 438.50M |
| Pretax Income | 492.90M |
| Net Income | 606.40M |
| EBITDA | 1.39B |
| EBIT | 438.50M |
| Earnings Per Share (EPS) | 2.35 |
Balance Sheet
The company has 4.01 billion in cash and 4.51 billion in debt, with a net cash position of -502.70 million.
| Cash & Cash Equivalents | 4.01B |
| Total Debt | 4.51B |
| Net Cash | -502.70M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 39.25B |
| Book Value Per Share | 99.19 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.93%, with operating and profit margins of 4.15% and 5.73%.
| Gross Margin | 70.93% |
| Operating Margin | 4.15% |
| Pretax Margin | 4.66% |
| Profit Margin | 5.73% |
| EBITDA Margin | 13.10% |
| EBIT Margin | 4.15% |
| FCF Margin | n/a |
Dividends & Yields
BOM:543064 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
| Earnings Yield | 0.50% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Sep 25, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |